financetom
Business
financetom
/
Business
/
Uber Technologies' Q1 Net Loss Widens, Revenue Rises
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Uber Technologies' Q1 Net Loss Widens, Revenue Rises
May 8, 2024 5:00 AM

07:36 AM EDT, 05/08/2024 (MT Newswires) -- Uber Technologies ( UBER ) reported a Q1 net loss Wednesday of $0.32 per diluted share, widening from a loss of $0.08 a year earlier.

Analysts polled by Capital IQ expected earnings of $0.22 per share.

Revenue for the quarter ended March 31 was $10.13 billion, up from $8.82 billion a year earlier. Analysts surveyed by Capital IQ expected $10.09 billion.

Gross bookings during the quarter came in at $37.65 billion, compared with $31.41 billion a year earlier.

The ride-hailing company said it expects Q2 gross bookings of $38.75 billion to $40.25 billion. Adjusted earnings before interest, taxes, depreciation, and amortization for the quarter will likely range between $1.45 billion and $1.53 billion, the company added.

Uber's ( UBER ) shares were down more than 6% in recent Wednesday premarket activity.

Price: 66.02, Change: -4.41, Percent Change: -6.26

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
The Ether Machine Announces Confidential Submission of a Draft Registration Statement on Form S-4 with the SEC
The Ether Machine Announces Confidential Submission of a Draft Registration Statement on Form S-4 with the SEC
Sep 16, 2025
NEW YORK, Sept. 16, 2025 (GLOBE NEWSWIRE) -- The Ether Machine, a planned public company following a pending business combination with Dynamix Corporation ( ETHM ) (“Dynamix”) and The Ether Reserve LLC, announced today the confidential submission by The Ether Machine of a draft registration statement on Form S-4 with the U.S. Securities and Exchange Commission (the “SEC”).  Andrew Keys,...
Medicines360 acquires global rights to PeriPeach™, advancing new maternal health technology through the 360 Innovation Hub™
Medicines360 acquires global rights to PeriPeach™, advancing new maternal health technology through the 360 Innovation Hub™
Sep 16, 2025
SAN FRANCISCO, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Medicines360, a women’s health innovation organization with a mission to be a catalyst for change, today announced that it has acquired global licensing rights to PeriPeach, an investigational medical device designed to prevent severe perineal tears during birth, from Fruits of Labor, Inc. PeriPeach will now advance through the 360 Innovation Hub,...
Premier American Uranium Completes Acquisition of Nuclear Fuels
Premier American Uranium Completes Acquisition of Nuclear Fuels
Sep 16, 2025
TORONTO, Sept. 16, 2025 /PRNewswire/ - Premier American Uranium Inc. ( PAUIF ) (PUR or Premier American Uranium) (TSXV: PUR)  and Nuclear Fuels Inc. ( NFUNF ) (NF or Nuclear Fuels) (CSE: NF) are pleased to announce the completion of the previously announced arrangement (the Arrangement) whereby Premier American Uranium ( PAUIF ) has acquired all of the issued and...
Market Chatter: Eli Lilly's Weight-Loss Pill May Get FDA Approval by Year-End
Market Chatter: Eli Lilly's Weight-Loss Pill May Get FDA Approval by Year-End
Sep 16, 2025
07:43 AM EDT, 09/16/2025 (MT Newswires) -- Eli Lilly's ( LLY ) investigational oral weight-loss drug orforglipron could be approved by the US Food and Drug Administration before the end of the year under a new one-to-two-month priority review process, Reuters reported Tuesday, citing Wall Street analysts. Analysts see the drug as a strong candidate for the fast-track program, which...
Copyright 2023-2026 - www.financetom.com All Rights Reserved